Clinical trial
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00356759 |
|---|---|
| Title | Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients |
| Official title | A Randomized Double-blind Study of 4-weekly Versus 12-weekly Monitoring of Stable Patients on Long-term Anticoagulation With Warfarin |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | The Physicians' Services Incorporated Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Heart Valve Diseases, Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Dosing warfarin every 12 weeks, sham INRs 2 out of 3 times |
| Enrollment | 250 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Jul 26, 2006 |
| Last update posted | Aug 22, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: